![An update for atypical haemolytic uraemic syndrome: Diagnosis and treatment. A consensus document | Nefrología An update for atypical haemolytic uraemic syndrome: Diagnosis and treatment. A consensus document | Nefrología](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/S2013251415000991:gr3.jpeg?xkr=ue/ImdikoIMrsJoerZ+w92lL8PRnKGMnsiVXV6EVJ5QRkjJZIKj2umwUyY+cL6K8cyMCoG0zLrx/ORKa7YTjKXhS6q7NEKZlvMcFs8CzIramwFU2hRK1bXCPGPRtLMuPm4BoUu6/j4p7E9Wrt5b2lpR2tNJKfWLyf0xkKbGRe/RlELR85EWOwyLcyzb+DqLIN/Ir2EItrJIO1VryvMiXm31QdaXAz4strmINJes4nwCajdBAwGvoWb3/9v3rcmbEjhzeMQ4x/jYYC0IZl1gL1Mi/U5VAG1NLM7wVaBP/m2wJyruA34D8c4vVHL0+kZpM)
An update for atypical haemolytic uraemic syndrome: Diagnosis and treatment. A consensus document | Nefrología
![Frontiers | Complement in Thrombotic Microangiopathies: Unraveling Ariadne's Thread Into the Labyrinth of Complement Therapeutics Frontiers | Complement in Thrombotic Microangiopathies: Unraveling Ariadne's Thread Into the Labyrinth of Complement Therapeutics](https://www.frontiersin.org/files/Articles/441391/fimmu-10-00337-HTML/image_m/fimmu-10-00337-g001.jpg)
Frontiers | Complement in Thrombotic Microangiopathies: Unraveling Ariadne's Thread Into the Labyrinth of Complement Therapeutics
![Differentiating Hemolysis, Elevated Liver Enzymes, and Low Platelet Count Syndrome and Atypical Hemolytic Uremic Syndrome in the Postpartum Period | Hypertension Differentiating Hemolysis, Elevated Liver Enzymes, and Low Platelet Count Syndrome and Atypical Hemolytic Uremic Syndrome in the Postpartum Period | Hypertension](https://www.ahajournals.org/cms/asset/dec35835-6852-49e2-b1d1-e74a365f1336/hypertensionaha.121.17311.fig04.jpg)
Differentiating Hemolysis, Elevated Liver Enzymes, and Low Platelet Count Syndrome and Atypical Hemolytic Uremic Syndrome in the Postpartum Period | Hypertension
![Atypical Hemolytic Uremic Syndrome Occurring After Receipt of mRNA-1273 COVID-19 Vaccine Booster: A Case Report - American Journal of Kidney Diseases Atypical Hemolytic Uremic Syndrome Occurring After Receipt of mRNA-1273 COVID-19 Vaccine Booster: A Case Report - American Journal of Kidney Diseases](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/8a2c7468-7082-468f-9045-6c4d2eaac2fd/gr1_lrg.jpg)
Atypical Hemolytic Uremic Syndrome Occurring After Receipt of mRNA-1273 COVID-19 Vaccine Booster: A Case Report - American Journal of Kidney Diseases
![Pulse Cyclophosphamide Therapy and Clinical Remission in Atypical Hemolytic Uremic Syndrome With Anti–Complement Factor H Autoantibodies - American Journal of Kidney Diseases Pulse Cyclophosphamide Therapy and Clinical Remission in Atypical Hemolytic Uremic Syndrome With Anti–Complement Factor H Autoantibodies - American Journal of Kidney Diseases](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2004086973/2016775340/gr1.jpg)
Pulse Cyclophosphamide Therapy and Clinical Remission in Atypical Hemolytic Uremic Syndrome With Anti–Complement Factor H Autoantibodies - American Journal of Kidney Diseases
![Use of Highly Individualized Complement Blockade Has Revolutionized Clinical Outcomes after Kidney Transplantation and Renal Epidemiology of Atypical Hemolytic Uremic Syndrome | American Society of Nephrology Use of Highly Individualized Complement Blockade Has Revolutionized Clinical Outcomes after Kidney Transplantation and Renal Epidemiology of Atypical Hemolytic Uremic Syndrome | American Society of Nephrology](https://jasn.asnjournals.org/content/jnephrol/30/12/2449/F1.large.jpg)
Use of Highly Individualized Complement Blockade Has Revolutionized Clinical Outcomes after Kidney Transplantation and Renal Epidemiology of Atypical Hemolytic Uremic Syndrome | American Society of Nephrology
![Expert Statements on the Standard of Care in Critically Ill Adult Patients With Atypical Hemolytic Uremic Syndrome - CHEST Expert Statements on the Standard of Care in Critically Ill Adult Patients With Atypical Hemolytic Uremic Syndrome - CHEST](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/a3f35e2d-12f1-4211-bf1b-1a2031ef33df/gr1_lrg.jpg)
Expert Statements on the Standard of Care in Critically Ill Adult Patients With Atypical Hemolytic Uremic Syndrome - CHEST
![Eculizumab treatment and discontinuation in pediatric patients with atypical hemolytic uremic syndrome: a multicentric retrospective study | SpringerLink Eculizumab treatment and discontinuation in pediatric patients with atypical hemolytic uremic syndrome: a multicentric retrospective study | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40620-021-01212-w/MediaObjects/40620_2021_1212_Figa_HTML.png)
Eculizumab treatment and discontinuation in pediatric patients with atypical hemolytic uremic syndrome: a multicentric retrospective study | SpringerLink
![Peri- and Post-operative Evaluation and Management of Atypical Hemolytic Uremic Syndrome (aHUS) in Kidney Transplantation - Advances in Chronic Kidney Disease Peri- and Post-operative Evaluation and Management of Atypical Hemolytic Uremic Syndrome (aHUS) in Kidney Transplantation - Advances in Chronic Kidney Disease](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/4e5d77f4-e60c-4dee-b016-e8e5a5c00669/gr1.jpg)
Peri- and Post-operative Evaluation and Management of Atypical Hemolytic Uremic Syndrome (aHUS) in Kidney Transplantation - Advances in Chronic Kidney Disease
![PDF) Atypical relapse of hemolytic uremic syndrome after transplantation | Jaap Groothoff - Academia.edu PDF) Atypical relapse of hemolytic uremic syndrome after transplantation | Jaap Groothoff - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/39499694/mini_magick20190222-32352-j6naae.png?1550890928)
PDF) Atypical relapse of hemolytic uremic syndrome after transplantation | Jaap Groothoff - Academia.edu
![Atypical and secondary hemolytic uremic syndromes have a distinct presentation and no common genetic risk factors - Kidney International Atypical and secondary hemolytic uremic syndromes have a distinct presentation and no common genetic risk factors - Kidney International](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/64dbc196-dea6-4d7e-962e-2ce53e59e87c/fx1_lrg.jpg)
Atypical and secondary hemolytic uremic syndromes have a distinct presentation and no common genetic risk factors - Kidney International
![Risk of Atypical HUS Among Family Members of Patients Carrying Complement Regulatory Gene Abnormality - Kidney International Reports Risk of Atypical HUS Among Family Members of Patients Carrying Complement Regulatory Gene Abnormality - Kidney International Reports](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/36ecf6fd-71cc-4840-b192-1ef16228a636/fx1_lrg.jpg)
Risk of Atypical HUS Among Family Members of Patients Carrying Complement Regulatory Gene Abnormality - Kidney International Reports
![Atypical and secondary hemolytic uremic syndromes have a distinct presentation and no common genetic risk factors - Kidney International Atypical and secondary hemolytic uremic syndromes have a distinct presentation and no common genetic risk factors - Kidney International](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/6b9b4a9b-023b-46a7-8eb3-ff80a614efb9/fx1.jpg)
Atypical and secondary hemolytic uremic syndromes have a distinct presentation and no common genetic risk factors - Kidney International
![Improved Survival in Thrombotic Thrombocytopenic Purpura–Hemolytic Uremic Syndrome — Clinical Experience in 108 Patients | NEJM Improved Survival in Thrombotic Thrombocytopenic Purpura–Hemolytic Uremic Syndrome — Clinical Experience in 108 Patients | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/1991/nejm_1991.325.issue-6/nejm199108083250605/production/images/img_medium/nejm199108083250605_f3.jpeg)
Improved Survival in Thrombotic Thrombocytopenic Purpura–Hemolytic Uremic Syndrome — Clinical Experience in 108 Patients | NEJM
![Early Eculizumab Withdrawal in patients with aHUS in native kidneys is Safe and Cost-Effective: results of the CUREiHUS study - Kidney International Reports Early Eculizumab Withdrawal in patients with aHUS in native kidneys is Safe and Cost-Effective: results of the CUREiHUS study - Kidney International Reports](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/d7d986c8-7a2c-4653-afad-cb4ed54d951f/fx1_lrg.jpg)
Early Eculizumab Withdrawal in patients with aHUS in native kidneys is Safe and Cost-Effective: results of the CUREiHUS study - Kidney International Reports
![Preemptive plasma therapy prevents atypical hemolytic uremic syndrome relapse in kidney transplant recipients - European Journal of Internal Medicine Preemptive plasma therapy prevents atypical hemolytic uremic syndrome relapse in kidney transplant recipients - European Journal of Internal Medicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/1bdbb101-3df5-4028-9f93-650f25df9123/fx1.jpg)